InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the full record of transactions filed by Suri Rajeev, 董事. Director active across 2 companies, notably STRYKER CORP. Aggregated, 9 filings have been logged. Activity tracked since 5 May 2021. The latest transaction was disclosed on 8 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Suri Rajeev
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
560 股0Common StockSEC:0000310764-25-000084:0
1,600 股0$.0001 par value common stockSEC:0000950170-24-104771:0
1,000 股0$.0001 par value common stockSEC:0000950170-24-067970:0
653 股0Common StockSEC:0000310764-24-000078:0
258,051 股$.0001 par value common stockSEC:0001209191-23-033278:0
705 股0Common StockSEC:0000310764-23-000085:0
841 股0Common StockSEC:0000310764-23-000076:0
693 股0Common StockSEC:0000310764-22-000075:0
991 股0Common StockSEC:0000310764-21-000083:0
9 条申报中的 9 条
About Suri Rajeev
Rajeev Suri is a Director at Stryker Corp. In this role, he participates in the strategic direction of the company and important decision-making. His expertise in the medical sector is valuable to the board.
